enVVeno Medical appoints Jennifer Bright as CFO, replacing Craig Glynn

enVVeno Medical Corp

Craig Glynn resigned as CFO effective May 19, 2025; will serve as consultant for transition.
Jennifer Bright appointed CFO; 25+ yr CPA, ex-CFO of BIOLASE, salary $300K, bonus up to 40%.
Bright awarded 350,000 stock options at $3.62/share, vesting over 3 years with 1-year cliff.
No disagreement with Glynn; standard employment and indemnification agreements signed.

item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jennifer Bright

Chief Financial Officer

NVNO · enVVeno Medical Corp

Effective: 2025-05-19
Filed: May 20, 2025 23:59 UTC

On May 19, 2025, the Board of Directors (the “ Board ”) of enVVeno Medical Corporation (the “ Company ”) appointed Jennifer Bright as Chief Financial Officer of the Company.

Departed

Craig Glynn

Chief Financial Officer

NVNO · enVVeno Medical Corp

Effective: 2025-05-19
Successor: Jennifer Bright
Filed: May 20, 2025 23:59 UTC

On May 19, 2025, Craig Glynn resigned as Chief Financial Officer of the Company.

Source: SEC EDGAR

accession 0001641172-25-011729

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.